Covid-19-vaccines-immunogenic-in-people-with-rheu... - PMRGCAuk

PMRGCAuk

21,029 members39,696 posts

Covid-19-vaccines-immunogenic-in-people-with-rheumatic-diseases

PMRpro profile image
PMRproAmbassador
17 Replies

rheumatology.medicinematter...?

This applies to people with autoimmune disorders and who take other medications besides pred but it does suggest that we will develop a good level of immunity AFTER the second shot.

It must be emphasised - please do not rely on a single shot providing the level of immunity found in clinical trials which are ideal conditions not real life.

Written by
PMRpro profile image
PMRpro
Ambassador
To view profiles and participate in discussions please or .
Read more about...
17 Replies
fmkkm profile image
fmkkm

Thank you! Very needed data now coming out.

alvertta profile image
alvertta

Thank you.

Frewen1 profile image
Frewen1

Thanks for that, PMRpro

Boss302Fan profile image
Boss302Fan

Ugh! Got to be be a healthcare professional to subscribe.☹️

PMRpro profile image
PMRproAmbassador in reply to Boss302Fan

? I get updates - so I must have subscribed and it is free ...

Boss302Fan profile image
Boss302Fan in reply to PMRpro

Was able to read the article with no problem. Felt the site would be worthwhile having access to. When registering I entered my email address. Beneath were a selection of one of two choices. One I was a healthcare provider and the other I wasn’t. I’m not. It came back stating registration only open to healthcare providers which I take issue with as imo scientific research findings should be open to all. Why the restriction. If I wanted to subscribe to the New England Journal of Medicine they’d take my money and say thank you.

Rugger profile image
Rugger in reply to Boss302Fan

I had no problem opening / reading the article - I'm in the UK.

readingbooks profile image
readingbooks in reply to Rugger

I didn't either in Canada.

Bcol profile image
Bcol

Ta.

123-go profile image
123-go

Thank you. A bit early in the day for me to try to decipher scientific language (my excuse) but got the gist. 🙂

Rugger profile image
Rugger

Thank you. That's good to read. I noticed it was the Pfizer vaccine, so let's hope the AZ behaves the same!

PMRpro profile image
PMRproAmbassador in reply to Rugger

The other reports I have read started with Pfizer as it was the first to be used but over time the others were included too. UK data will be slow because of the 12 week delay between 1st and 2nd shots.

Frenchduck profile image
Frenchduck

Thanks for this link. At least research is taking place and in time we should know more of the answers to our questions.

Coffeebeans profile image
Coffeebeans

That's good news thankyou.

And once we get some longer term information we will know about booster requirements too.

maria40 profile image
maria40

It presumably applies also to AZ though it only mention MNRA vaccines?

PMRpro profile image
PMRproAmbassador in reply to maria40

Not necessarily but AZ started later so data is behind

DDKRM profile image
DDKRM

Reassuring to hear 2nd jab is effective as I found out via a test for antibodies that even though I’ve had my first jab of the Pfizer vaccine I didn’t have enough antibodies to register on the test.

Not what you're looking for?

You may also like...

Risk-factors-for-long-haul-COVID-in-people-with-rheumatic-diseases-identified

https://www.news-medical.net/news/20211107/Risk-factors-for-long-haul-COVID-in-people-with-rheumatic

Immunity and Covid-19 podcast: Part 2

Last month I put up the link to the first of this series - here is the second part, as promised....

Podcast about the immune system and how it works, with a mention of Covid-19 ...

In this podcast, Sara Booth, University of Cambridge, talks to Professor Sarah Rowlands (Florey...

Press Release: People with rare autoimmune rheumatic diseases at increased risk of death during COVID-19 pandemic.

Paul Howard of LupusUK has just posted this link and I thought it was also relevant to us as it...

COVID-19 Global Rheumatology Alliance Survey

The COVID-19 Global Rheumatology Alliance is calling on people 18+ with rheumatic diseases, and...